Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
Condition(s):Covid-19; Pneumonia, Viral; Sars-CoV2Last Updated:February 2, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Covid-19; Pneumonia, Viral; Sars-CoV2Last Updated:February 2, 2022Active, not recruiting
Condition(s):Seasonal Allergic RhinitisLast Updated:February 2, 2017Completed
Condition(s):COVID 19Last Updated:June 10, 2022Terminated
Condition(s):COVID-19Last Updated:June 24, 2021Completed
Condition(s):Perennial Allergic RhinitisLast Updated:July 24, 2014Completed
Condition(s):Perennial Allergic RhinitisLast Updated:June 13, 2012Completed
Condition(s):AsthmaLast Updated:April 26, 2017Completed
Condition(s):Asthma, BronchialLast Updated:July 25, 2019Completed
Condition(s):Bronchial AsthmaLast Updated:February 10, 2017Completed
Condition(s):AsthmaLast Updated:October 21, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.